483
Dhaliwal Pharmaceuticals Laboratories, LLCFDA 483 - Dhaliwal Pharmaceuticals Laboratories, LLC - March 01, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Dhaliwal Pharmaceuticals Laboratories, LLC, an OTC drug manufacturer in Mesquite, TX, was cited for failing to follow written production and process control procedures. Specifically, the firm had not completed process validation studies for an OTC topical drug product, leading to the release of unvalidated batches. This indicates a significant lapse in quality control and adherence to manufacturing standards.
Open in Dashboard
ID · 966efe70-32ac-40c8-8ed4-e9f8a2f9337b